A high-throughput digital PCR premix, its kit, and its applications

By developing high-throughput digital PCR premixes and kits containing specific components, the problem of multi-target gene detection that is difficult to achieve with traditional PCR technology has been solved, enabling efficient and sensitive multi-gene detection and expanding the clinical application of molecular diagnostics.

CN123063508APending Publication Date: 2026-11-10NANJING PREGENE BIOTECHNOLOGY CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410786058.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-18
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Traditional PCR technology is difficult to detect multiple targets and different types of genes simultaneously and efficiently, resulting in unstable reaction systems, the production of non-specific products, and limitations on the throughput of detection information and the scope of clinical applications.

Method used

A high-throughput digital PCR premix was developed, comprising KCl, MgCl2, (NH4)2SO4, Tris-HCl, β-mercaptoethanol, BSA, dNTPs, dUTPs, UDG enzyme, DNA hot-start Taq enzyme, stabilizers and enhancers such as Tween 20, Tween 80, a polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide, DMSO, betaine, and glycerol, for the preparation of a high-throughput digital PCR kit for the detection of methylated genes, mutant genes, and pathogenic microbial genes.

Benefits of technology

It improves the stability and sensitivity of multi-target gene detection, overcomes the signal limitations of traditional PCR premix solutions, supports rapid and economical molecular diagnostic applications, increases the amount of detection information and specific recognition capabilities, reduces non-specific amplification, and expands the clinical application scenarios of molecular diagnostics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123063508A_ABST
    Figure CN123063508A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of digital PCR detection, specifically relating to a high-throughput digital PCR premix, its kit, and its applications. The components of the high-throughput digital PCR premix include: KCl, MgCl2, (NH4)2SO4, Tris-HCl, β-mercaptoethanol, BSA, dNTPs, dUTPs, enzymes, stabilizers, and enhancers. Using the premix of this invention, nucleic acid quantification can be performed on three types of genes: mutations, pathogens, and methylation. This breakthrough surpasses the signal strength limitations of traditional PCR premix systems, offering the dual advantages of high detection information and high sensitivity. It addresses long-standing pain points in molecular diagnostics, creating a "fast, efficient, and cost-effective" next-generation molecular diagnostic platform. It allows for simple, rapid, and economical implementation of clinical applications that previously required complex equipment, demonstrating broad application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of digital PCR detection, specifically relating to a high-throughput digital PCR premix, its kit, and its applications. Background Technology

[0002] Since its introduction in the mid-1980s, PCR technology has undergone more than 40 years of development and has become a crucial technique in the field of molecular diagnostics. From qualitative to relative quantification and then to absolute quantification, PCR technology has been continuously upgraded, with its sensitivity and accuracy constantly improving. However, PCR has always faced a major challenge: it is difficult to perform simultaneous detection of multiple targets and different genes. As the number of targets increases, the entire reaction system becomes very unstable, producing a large number of non-specific products that interfere with the final detection results. The limited throughput of detection information also restricts the clinical application of PCR.

[0003] Digital PCR is an absolute quantification technique for nucleic acid molecules, a cutting-edge nucleic acid quantification technology based on single-molecule PCR. However, traditional digital PCR premixes have limitations in the number of amplification sites and the detection of different genes. Therefore, to address this limitation, there is an urgent need to develop a high-throughput digital PCR premix that can overcome the limitations of traditional PCR premix systems in detecting signals by orders of magnitude. Summary of the Invention

[0004] The technical problem to be solved by the present invention is to provide a high-throughput digital PCR premix solution to address the shortcomings of the prior art.

[0005] Another technical problem to be solved by the present invention is to provide a kit containing the above-mentioned high-throughput digital PCR premix.

[0006] The final technical problem to be solved by this invention is to provide the application of the above-mentioned high-throughput digital PCR premix or kit.

[0007] To solve the above-mentioned technical problems, the technical solution adopted by the present invention is as follows:

[0008] A high-throughput digital PCR premix comprises the following components: KCl, MgCl2, (NH4)2SO4, Tris-HCl, β-mercaptoethanol, BSA, dNTP, dUTP, enzyme, stabilizer, and enhancer.

[0009] The enzymes mentioned include any one or a combination of several of UDG enzymes and DNA hot-start Taq enzymes.

[0010] The stabilizer includes any one or a combination of several of the following: Tween 20, Tween 80, and polymers of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide.

[0011] The reinforcing agent includes any one or a combination of several of DMSO, betaine, formamide, and glycerol.

[0012] Preferably, the high-throughput digital PCR premix comprises the following components: KCl, MgCl2, (NH4)2SO4, Tris-HCl, β-mercaptoethanol, BSA, dNTP, dUTP, UDG enzyme, DNA hot-start Taq enzyme, a polymer of methyl ethylene oxide and 1,2-ethylenediamine and ethylene oxide, glycerol, DMSO, and betaine.

[0013] Preferably, the high-throughput digital PCR premix comprises the following components: 4× reaction buffer: 25–80 mM MCl, 2–10 mM MgCl2, 30–100 mM (NH4)2SO4, 5–35 mM Tris-HCl pH 7.8–8.8, 0.2–2 mM β-mercaptoethanol, 50–300 ng / μl BSA, 0.1–2.5 mM dNTP, 0.02–1.75 mM dUTP, 10–100 U / ml UDG enzyme, 100–250 U / ml DNA hot-start Taq enzyme, 0.05–2% (v / v) of a polymer of methyl ethylene oxide and 1,2-ethylenediamine and ethylene oxide, 1–10% (v / v) of glycerol, 0.5–10% (v / v) of DMSO, and 0.1–1 M betaine.

[0014] More preferably, the high-throughput digital PCR premix comprises the following components: 4× reaction buffer: 35mM M KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 1% polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide, 2% glycerol, 1% DMSO, and 1M betaine.

[0015] A kit for quantitative detection of genes based on high-throughput digital PCR is also within the scope of protection of this invention.

[0016] Specifically, the kit includes the aforementioned high-throughput digital PCR premix.

[0017] The application of the above-mentioned high-throughput digital PCR premix or the above-mentioned kit in the preparation of reagents for quantitative detection of methylated genes is also within the scope of protection of this invention.

[0018] The methylation gene mentioned is a lung cancer methylation gene, including any one or a combination of several of LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, HOXA7, LRRC8A, NCOR2, and TRAP1.

[0019] Specifically, information about the methylated gene has been disclosed in patent US20200255904A1.

[0020] The application of the above-mentioned high-throughput digital PCR premix or the above-mentioned kit in the preparation of reagents for quantitative detection of mutant genes is also within the scope of protection of this invention.

[0021] The mutated gene is a mutated gene of epidermal growth factor receptor (EGFR); specifically, the mutated gene of EGFR is: EGFR exon 19 deletion at positions E746-A750, EGFR T790M, or EGFR L858R.

[0022] Specifically, the relevant information about the mutated gene has been published in the article [1] Chen, Hongyuan, et al. Establishment of multiplex allele-specific blocker PCR for enrichment and detection of 4 common EGFR mutations in non-small cell lung cancer [J].

[0023] The application of the above-mentioned high-throughput digital PCR premix or the above-mentioned kit in the preparation of reagents for quantitative detection of pathogenic microorganism genes is also within the scope of protection of this invention.

[0024] The pathogenic microorganisms mentioned include any one or a combination of several of the following: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii.

[0025] Specifically, the relevant information about the pathogenic microorganisms has been published in the article [2] Gadsby, NJ, et al. Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections [J].

[0026] A method for quantitative detection of genes using the above-mentioned high-throughput digital PCR premix is ​​also within the scope of protection of this invention, specifically including the following steps:

[0027] (1) Preparation of ddPCR reaction system: Add 10-12 μl of high-throughput digital PCR premix, 1.2-1.6 μl of probe / each layer, 0.12-0.64 μl of upstream primer / each layer, 0.12-0.64 μl of downstream primer / each layer, 2-4 μl of template DNA, and ddH2O to a final volume of 40 μl. Mix and centrifuge with shaking.

[0028] (2) Add 40 μl of ddPCR reaction system and 80 μl of droplet generating oil to the well of the microfluidic generation chip in sequence. Stable water-in-oil microdroplets are generated by the microdroplet generator. Transfer the microdroplets to a 96-well plate. After heat sealing the 96-well plate, place it in a PCR instrument for microdroplet PCR amplification.

[0029] (3) After the droplet PCR reaction in step (2) is completed, take out the 96-well plate and put it into the droplet analyzer for gene detection and analysis.

[0030] The gene in question is a methylated gene, a mutated gene, or a pathogenic microorganism gene; the method described is a non-disease diagnostic method.

[0031] Beneficial effects:

[0032] (1) This invention develops a high-throughput digital PCR premix that is compatible with the detection of three types of genes: mutation, pathogen, and methylation. It breaks through the order of magnitude of detection signals in traditional PCR premix systems and has the dual advantages of high detection information and high detection sensitivity. It solves the long-standing pain point of molecular diagnostics and can work with PCR instruments and other equipment to create a "fast, efficient, and cost-effective" next-generation molecular diagnostic platform. It can easily, quickly, and economically realize clinical applications that originally required complex equipment, support IVD admission and deployment, and save R&D costs and accelerate the development of reagent formulations.

[0033] (2) The high-throughput digital PCR premix developed in this invention can make droplets more stable and prevent them from breaking and fusing. It does not damage the structure of proteins, reduces the damage to the original interactions between proteins, acts as an renaturing antigen, improves the specific recognition ability, reduces the non-specific binding of antibodies, reduces non-specific amplification, and also has a decontamination effect.

[0034] (3) The high-throughput digital PCR premix developed in this invention can improve DNA amplification efficiency by reducing the formation of secondary structures.

[0035] (4) After the high-throughput digital PCR premix described in this invention is mixed with the oil phase, the droplets still maintain stable performance and basically do not merge after being generated by the sample preparation instrument and subjected to high-temperature thermal cycling of PCR.

[0036] (5) After bio-amplification using the high-throughput digital PCR premix solution described in this invention, the amplification results are more accurate.

[0037] (6) The high-throughput PCR premix developed in this invention can solve the limitations of traditional digital PCR premix in terms of the number of amplification sites and the detection of different genes during amplification. With high-dimensional signal reading and analysis capabilities, it can expand the boundaries of molecular diagnostics in clinical applications and achieve 90% clinical application of the NGS platform with the high efficiency and cost-effectiveness of PCR. Attached Figure Description

[0038] The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments, and the advantages of the present invention in the above and / or other aspects will become clearer.

[0039] Figure 1 The droplet morphology is shown in the diagram after adding a polymer of methyl ethylene oxide, 1,2-ethylenediamine, and ethylene oxide to a high-throughput digital PCR premix.

[0040] Figure 2 The droplet morphology is shown in the diagram of droplet formation after adding Tween 20 to the high-throughput digital PCR premix.

[0041] Figure 3 The droplet morphology is shown in the diagram of droplet formation after adding Tween 80 to the high-throughput digital PCR premix.

[0042] Figure 4 Signal graph after adding betaine and DMSO to the high-throughput digital PCR premix.

[0043] Figure 5 Amplification efficiency curves for adding betaine and DMSO to high-throughput digital PCR premix.

[0044] Figure 6Signal graph after amplification of high-throughput digital PCR premix with only glycerol added.

[0045] Figure 7 The amplification efficiency curve is shown for high-throughput digital PCR premix with only glycerol added.

[0046] Figures 8 to 17 The images show the signal patterns after amplification of methylated genes (LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, HOXA7, LRRC8A, NCOR2, TRAP1), in that order.

[0047] Figures 18-21 The images, in order, show the signal patterns after amplification of the mutant genes (EGFR Exon 19deletion, EGFR T790M, EGFR L858R, and β-actin).

[0048] Figures 22-29 The images, in order, show the signal amplification results of genes from the pathogenic microorganisms (Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii). Detailed Implementation

[0049] Unless otherwise specified, the experimental methods described in the following examples are conventional methods; the reagents and materials described are commercially available unless otherwise specified.

[0050] In the following examples, the UDG enzyme was purchased from Novizan (product number P051-01-AA); the DNA hot-start Taq enzyme was purchased from Phytobio (product number MD006).

[0051] In the following embodiments, the methylated genes: LINCO1158 gene, CCDC181 gene, ZNF781 gene, MARCH11 gene, VWC2 gene, SLC9A3 gene, and HOXA7 gene have been disclosed in patent US20200255904A1; the EGFR mutant genes: EGFR Exon 19deletion, EGFR T790M, and EGFRL858R have been disclosed in the article [1] Chen, Hongyuan, et al. Establishment of multiplexallele-specific blocker PCR for enrichment and detection of 4 common EGFR mutations in non-small cell lung cancer[J].; the pathogenic microorganisms: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Moraxella catarrhalis Information on catarrhalis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii has been published in the article [2] Gadsby, NJ, et al. Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections [J].

[0052] Example 1: Screening of components in high-throughput digital PCR premix

[0053] 1. Screening of stabilizers

[0054] A tenfold mixture was prepared using seven methylated gene DNAs (LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, and HOXA7) plus three internal reference genes, and stabilizers were screened using the methylated VWC2 gene as the standard.

[0055] Tween 20, Tween 80, and the polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide were added to a high-throughput digital PCR premix to obtain a 40 μl reaction system. Then, the 40 μl reaction system and 80 μl of droplet-generating oil were added to the well of a microfluidic generation chip. After high-temperature thermal cycling on the digital PCR platform, stable water-in-oil droplets were generated through a droplet generator.

[0056] 40μl ddPCR reaction system: 10μl high-throughput digital PCR premix, 1.6μl probe, 0.32μl upstream primer, 0.32μl downstream primer, 2μl mixed template of 7-dymethylated gene DNA + 3 internal reference genes, ddH2O added to make up to 40μl, mix and centrifuge with shaking.

[0057] The high-throughput digital PCR premix is ​​divided into the following three types:

[0058] (1) 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 2% glycerol, 1% DMSO, 1M betaine, 1% methyl ethylene oxide polymerized with 1,2-ethylenediamine and ethylene oxide.

[0059] (2) 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 2% glycerol, 1% DMSO, 1M betaine, 1% Tween 20.

[0060] (3) 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 2% glycerol, 1% DMSO, 1M betaine, 1% Tween 80.

[0061] Figures 1-3The images show the state of droplets after high-temperature thermal cycling on a digital PCR platform under different stabilizers (magnified 200x under a microscope). As can be seen from the figures, the addition of stabilizers resulted in more stable droplets after high-temperature thermal cycling amplification, preventing breakage and fusion. The best droplet state was observed when a polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide was used as the stabilizer.

[0062] 2. Screening of reinforcing agents

[0063] A tenfold mixture was prepared using seven methylated gene DNAs (LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, and HOXA7) plus three internal reference genes, and enhancers were screened using the methylated VWC2 gene as the standard.

[0064] (1) Preparation of ddPCR reaction system: 10 μl high-throughput digital PCR premix, 1.6 μl probe, 0.32 μl upstream primer, 0.32 μl downstream primer, 2 μl mixed template of 7-dymethylated gene DNA + 3 internal reference genes, ddH2O added to 40 μl, mixed and centrifuged by shaking;

[0065] The specific components of the high-throughput digital PCR premix are as follows:

[0066] 1) 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 2% glycerol, 1% DMSO, 1M betaine, 1% Tween 80;

[0067] Or 2) 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 2% glycerol, 1% Tween 80.

[0068] (2) Add 40 μl of ddPCR reaction system and 80 μl of droplet generating oil to the well of the microfluidic generation chip in sequence. Stable water-in-oil microdroplets are generated by the microdroplet generator. Transfer the microdroplets to a 96-well plate. After heat sealing the 96-well plate, place it in a PCR instrument for microdroplet PCR amplification.

[0069] The methylated droplet PCR amplification program is as follows: 95℃, 10 min; 95℃, 15 s; 60℃, 20 s; 72℃, 35 s; 98℃, 10 min; 16℃ incubation; 55 cycles.

[0070] (3) After the droplet PCR reaction in step (2) is completed, the 96-well plate is taken out and placed into the droplet analyzer for detection and analysis.

[0071] When the specific components of the high-throughput digital PCR premix are as shown in Figure 1), the amplification signal and amplification efficiency curve of the methylated VWC2 gene are as follows: Figures 4-5 As shown; when the specific components of the high-throughput digital PCR premix are 2), the amplification signal and amplification efficiency curves of the methylated VWC2 gene are as follows. Figures 6-7 As shown in the figure, the addition of DMSO and betaine resulted in significant signal intensity of the methylated VWC2 gene in six different signal channels, with the droplets remaining aggregated rather than dispersed. In contrast, the addition of only glycerol as an enhancer resulted in dispersed droplets, indicating that the addition of DMSO and betaine is beneficial for improving gene amplification efficiency.

[0072] Example 2: Methylation detection verification (taking a 7-fold lung cancer methylation gene as an example)

[0073] (1) Preparation of ddPCR reaction system: Take 10 μl of high-throughput digital PCR premix, 1.6 μl of probe / each, 0.32 μl of upstream primer / each, 0.32 μl of downstream primer / each, 2 μl of 7-dopyl methylated gene DNA + 3-dopyl methylated gene mixed template, add ddH2O to make up to 40 μl, mix and then vortex and centrifuge;

[0074] The specific components of the high-throughput digital PCR premix are as follows: 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 1% polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide, 2% glycerol, 1% DMSO, and 1M betaine.

[0075] The methylated genes included LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, and HOXA7. LRRC8A, NCOR2, and TRAP1 were used as internal reference genes, serving as references when detecting changes in the expression levels of methylated genes. The corresponding methylation sites, primers used, and probe sequences for the above genes are shown in Table 1.

[0076] Table 1. Methylation sites, primers, and corresponding probes for methylated genes.

[0077]

[0078] (2) Add 40 μl of ddPCR reaction system and 80 μl of droplet generating oil to the well of the microfluidic generation chip in sequence. Stable water-in-oil microdroplets are generated by the microdroplet generator. Transfer the microdroplets to a 96-well plate. After heat sealing the 96-well plate, place it in a PCR instrument for microdroplet PCR amplification.

[0079] The droplet PCR amplification program is as follows: 95℃, 10 min; 95℃, 15 s; 60℃, 20 s; 72℃, 35 s; 98℃, 10 min; 16℃ incubation; 55 cycles.

[0080] (3) After the droplet PCR reaction in step (2) is completed, the 96-well plate is taken out and placed into the droplet analyzer for detection and analysis.

[0081] Experimental results are as follows Figures 8-17 As shown, Figures 8-14 Signal mapping for methylated genes (LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, HOXA7). Figures 15-17 Signal transduction maps of internal reference genes (LRRC8A, NCOR2, TRAP1). From Figures 8-14As can be seen, the positive droplets of the seven methylation genes (green in the figure represent positive droplets) showed strong amplification signals in six different signal channels, with a clear and even distribution of fluorescence intensity. Furthermore, the droplets aggregated without dispersion, indicating high amplification efficiency. Simultaneously, the LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, and HOXA7 genes exhibited clear boundaries in the FAM, CY7, CY5.5, ROX, CY5C, VIC, and FAM channels, respectively, showing no hybridization with other channels. Although both the LINCO1158 and HOXA7 genes are located in the FAM channel, their fluorescence intensity distributions differ within the signal channels, thus effectively distinguishing different methylation genes.

[0082] Example 3: Detection and verification of mutant genes (taking triple mutant genes as an example)

[0083] (1) Preparation of ddPCR reaction system: Take 10 μl of high-throughput digital PCR premix, 1.2 μl of probe / each, 0.12 μl of upstream primer / each, 0.12 μl of downstream primer / each, 2 μl of triplet mutant gene DNA + 1-pair internal reference gene mixed template, add ddH2O to make up to 40 μl, mix and then vortex and centrifuge;

[0084] The specific components of the high-throughput digital PCR premix are as follows: 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 1% polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide, 2% glycerol, 1% DMSO, and 1M betaine.

[0085] Among them, the mutant genes are EGFR mutant genes (EGFR Exon 19deletion, EGFR T790M, EGFRL858R). The corresponding mutation sites of EGFR genes, the primers used and the corresponding probe sequences are shown in Table 2.

[0086] Table 2. Information on the mutation sites, primers, and corresponding probes for the mutated genes.

[0087]

[0088]

[0089] (2) Add 40 μl of ddPCR reaction system and 80 μl of droplet generating oil to the well of the microfluidic generation chip in sequence. Stable water-in-oil microdroplets are generated by the microdroplet generator. Transfer the microdroplets to a 96-well plate. After heat sealing the 96-well plate, place it in a PCR instrument for microdroplet PCR amplification.

[0090] The microdroplet PCR amplification program for the mutant gene is as follows: 95℃, 10 min; 95℃, 15 s; 60℃, 50 s; 98℃, 10 min; 16℃ incubation; 55 cycles.

[0091] (3) After the droplet PCR reaction in step (2) is completed, the 96-well plate is taken out and placed into the droplet analyzer for detection and analysis.

[0092] Experimental results are as follows Figures 18-21 As shown, using the high-throughput digital PCR premix of this invention, the three mutant genes (EGFR Exon 19 deletion, EGFR T790M, and EGFR L858R) exhibited significant fluorescence intensity signals in six signal channels, indicating strong amplification signals. Furthermore, the droplets aggregated without dispersion, and the positive and negative droplets were clearly differentiated. Simultaneously, EGFR Exon 19 deletion showed a clear boundary in the FAM channel, EGFR T790M in the ROX channel, and EGFR L858R in the CY5.5 channel. Therefore, digital PCR using the self-developed high-throughput digital PCR premix of this invention not only provides strong amplification signals but also effectively distinguishes different mutant genes in different fluorescence signal channels.

[0093] Example 4: Detection and verification of pathogenic microorganisms (taking eight pathogenic microorganisms as an example)

[0094] (1) Preparation of ddPCR reaction system: Take 10 μl of high-throughput digital PCR premix, 1.6 μl of probe / each, 0.64 μl of upstream primer / each, 0.64 μl of downstream primer / each, and 2 μl of 8-pair pathogenic microorganism DNA mixed template, add ddH2O to make up to 40 μl, mix and then vortex and centrifuge.

[0095] The specific components of the high-throughput digital PCR premix are as follows: 4× reaction buffer: 35mM KCl, 5mM MgCl2, 60mM (NH4)2SO4, 30mM Tris-HCl buffer, pH 8.0, 0.65mM β-mercaptoethanol, 150ng / μl BSA, 0.4mM dNTP, 0.02mM dUTP, 30U / ml UDG enzyme, 250U / ml DNA hot-start Taq enzyme, 1% polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide, 2% glycerol, 1% DMSO, and 1M betaine.

[0096] The eight pathogenic microorganisms and their primers and corresponding probe sequences are shown in Table 3.

[0097] Table 3. Information on pathogenic microorganisms, their primers, and corresponding probes.

[0098]

[0099] (2) Add 40 μl of ddPCR reaction system and 80 μl of droplet generating oil to the well of the microfluidic generation chip in sequence. Stable water-in-oil microdroplets are generated by the microdroplet generator. Transfer the microdroplets to a 96-well plate. After heat sealing the 96-well plate, place it in a PCR instrument for microdroplet PCR amplification.

[0100] The microdroplet PCR amplification program for the pathogen gene is as follows: 95℃, 10 min; 95℃, 10 s; 62℃, 50 s; 98℃, 10 min; 16℃ incubation; 55 cycles.

[0101] (3) After the droplet PCR reaction in step (2) is completed, the 96-well plate is taken out and placed into the droplet analyzer for detection and analysis.

[0102] Experimental results are as follows Figures 22-29As shown in the figure, when digital PCR was performed using the self-developed high-throughput digital PCR premix of this invention, after infecting eight pathogenic microorganisms (Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii), the positive and negative droplets of the eight pathogenic microorganisms were clearly demarcated in the signal channel and showed an aggregated but not discrete state, indicating a strong amplification signal. Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii showed clear boundaries in the CY5.5, ROX, CY7, CY5C, FAM, CY5.5, ROX, and VIC channels, respectively, and did not hybridize with other channels. Although Streptococcus pneumoniae and Klebsiella pneumoniae were both located in the CY5.5 channel, and Haemophilus influenzae and Pseudomonas aeruginosa were both located in the ROX channel, their fluorescence intensity distributions in the signal channels differed. Therefore, while improving the amplification signal intensity and stability, this method can effectively distinguish these eight pathogenic microorganisms.

[0103] This invention provides a high-throughput digital PCR premix, its kit, and its application, along with a conceptual framework and method. Many methods and approaches exist for implementing this technical solution; the above description is merely a preferred embodiment of the invention. It should be noted that those skilled in the art can make various improvements and modifications without departing from the principles of this invention, and these improvements and modifications should also be considered within the scope of protection of this invention. All components not explicitly stated in this embodiment can be implemented using existing technologies.

Claims

1. A high-throughput digital PCR premix, characterized in that, It includes the following components: KCl, MgCl2, (NH4)2SO4, Tris-HCl, β-mercaptoethanol, BSA, dNTP, dUTP, enzyme, stabilizer and enhancer; The enzymes mentioned include any one or a combination of several of UDG enzymes and DNA hot-start Taq enzymes. The stabilizer includes any one or a combination of several of the following: Tween 20, Tween 80, and polymers of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide. The reinforcing agent includes any one or a combination of several of DMSO, betaine, formamide, and glycerol.

2. The high-throughput digital PCR premix according to claim 1, characterized in that, It includes the following components: 4× reaction buffer: 25-80mM KCl, 2-10mM MgCl2, 30-100mM (NH4)2SO4, 5-35mM Tris-HCl pH 7.8-8.8, 0.2-2mM β-mercaptoethanol, 50-300ng / μl BSA, 0.1-2.5mM dNTP, 0.02-1.75mM dUTP, 10-100U / ml UDG enzyme, 100-250U / ml DNA hot-start Taq enzyme, 0.05-2% (v / v) of a polymer of methyl ethylene oxide with 1,2-ethylenediamine and ethylene oxide, 1-10% (v / v) of glycerol, 0.5-10% (v / v) of DMSO, and 0.1-1M betaine.

3. A kit for quantitative detection of genes based on high-throughput digital PCR, characterized in that, Includes the high-throughput digital PCR premix as described in claim 1 or 2.

4. The use of the high-throughput digital PCR premix of claim 1 or 2 or the kit of claim 3 in the preparation of reagents for quantitative detection of methylated genes.

5. The application according to claim 4, characterized in that, The methylation genes mentioned are lung cancer methylation genes, including any one or a combination of several of LINCO1158, CCDC181, ZNF781, MARCH11, VWC2, SLC9A3, HOXA7, LRRC8A, NCOR2, and TRAP1.

6. The use of the high-throughput digital PCR premix of claim 1 or 2 or the kit of claim 3 in the preparation of reagents for quantitative detection of mutant genes.

7. The application according to claim 6, characterized in that, The mutated gene is a mutated gene of epidermal growth factor receptor EGFR; wherein the mutated gene of epidermal growth factor receptor EGFR is: deletion at position E746 to A750 of exon 19 of EGFR, EGFR T790M or EGFR L858R.

8. The use of the high-throughput digital PCR premix of claim 1 or 2 or the kit of claim 3 in the preparation of reagents for quantitative detection of pathogenic microorganism genes.

9. The application according to claim 8, characterized in that, The pathogenic microorganisms mentioned include any one or a combination of several of the following: Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii.

10. A method for quantitative detection of genes using the high-throughput digital PCR premix solution according to claim 1 or 2, characterized in that, Includes the following steps: (1) Preparation of ddPCR reaction system: Add 10-12 μl of high-throughput digital PCR premix, 1.2-1.6 μl of probe / each layer, 0.12-0.64 μl of upstream primer / each layer, 0.12-0.64 μl of downstream primer / each layer, 2-4 μl of template DNA, and ddH2O to a final volume of 40 μl. Mix and centrifuge with shaking. (2) Add 40 μl of ddPCR reaction system and 80 μl of droplet generating oil to the well of the microfluidic generation chip in sequence. Stable water-in-oil microdroplets are generated by the microdroplet generator. Transfer the microdroplets to a 96-well plate. After heat sealing the 96-well plate, place it in a PCR instrument for microdroplet PCR amplification. (3) After the droplet PCR reaction in step (2) is completed, take out the 96-well plate and put it into the droplet analyzer for gene detection and analysis. The gene in question is a methylated gene, a mutated gene, or a pathogenic microorganism gene; the method described is a non-disease diagnostic method.

Citation Information

Patent Citations

  • DNA methylation biomarkers for cancer diagnosing

    US20200255904A1